We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Wearable Biosensor Monitors Patients for Five Days

By HospiMedica International staff writers
Posted on 20 Dec 2017
Print article
Image: The VitalPatch sensor can monitor eight patient parameters (Photo courtesy of Vital Connect).
Image: The VitalPatch sensor can monitor eight patient parameters (Photo courtesy of Vital Connect).
A wireless single patient, fully disposable vital signs biosensor provides convenience for caregivers and comfort for patients.

The Vital Connect (Campbell, CA, USA) VitalPatch is a state-of-the-art biosensor patch that monitors eight vital signs continuously, including heart rate, heart rate variability, respiratory rate, single-lead electrocardiogram (ECG), skin temperature, body posture, fall detection, and activity. The patch is powered by a disposable zinc air battery designed to hold up for 120 hours, in line with the U.S. national average of hospital patient length of stay of 4.5 days. VitalPatch can also be used beyond the hospital walls where continuous monitoring is needed, including post-discharge monitoring, remote patient monitoring, and in clinical trials.

Proprietary SensorFusion algorithms process thousands of data points per minute to produce accurate robust measurements, which are transmitted wirelessly via Wi-Fi to the VitalConnect Platform, which integrates the biosensor with mobile and cloud-based software and analytics so that patients can be monitored around the clock. Data analytics can help improve care for patients at risk, such as those suffering from sepsis, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and others. They can also help to detect early changes in patient physiology, potentially reducing mortality rates and days spent in the intensive care unit (ICU).

“We envision a hospital of the future where inpatient and outpatient care needs integrate more seamlessly to enable a patient-centric model of care that is truly preventative and real-time,” said Nersi Nazari, PhD, CEO and founder of VitalConnect. “The extended wear duration for our fully disposable VitalPatch biosensor supports our commitment toward improving patient care and enabling nurses and physicians to have real-time insight into their patients' vitals and well-being.”

Related Links:
Vital Connect

Print article


Copyright © 2000-2018 Globetech Media. All rights reserved.